US Stock MarketDetailed Quotes

SCNI Scinai Immunotherapeutics

Watchlist

3.665
-0.215-5.54%

Trading May 30 15:19 ET

2.13MMarket Cap-229P/E (TTM)

Scinai Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-65.40%4.87M

-22.99%6.36M

-34.02%7.51M

-29.73%10.8M

-18.99%14.08M

-23.28%8.26M

-7.13%11.38M

5.64%15.37M

-Cash and cash equivalents

-65.40%4.87M

-22.99%6.36M

-34.02%7.51M

-29.73%10.8M

-18.99%14.08M

-23.28%8.26M

-7.13%11.38M

5.64%15.37M

Receivables

232.73%366K

13.97%228K

-23.46%138K

-38.85%119K

12.24%110K

-54.83%200.04K

-77.77%180.3K

35.09%194.6K

-Other receivables

232.73%366K

13.97%228K

-23.46%138K

-38.85%119K

12.24%110K

-54.83%200.04K

-77.77%180.3K

35.09%194.6K

Prepaid assets

57.78%71K

----

-80.26%45K

----

Restricted cash

0.00%140K

--122K

--126K

--127K

-2.10%140K

----

Total current assets

-62.09%5.45M

-20.67%6.71M

-32.77%7.77M

-29.03%11.05M

-19.46%14.37M

-24.52%8.46M

-11.52%11.56M

5.93%15.56M

Non current assets

Net PPE

-5.29%12.03M

-2.95%11.87M

-5.33%12.13M

-13.63%12.25M

-10.54%12.7M

-11.46%12.23M

-7.50%12.81M

4.68%14.18M

-Gross PPE

-1.89%14.83M

-2.95%11.87M

-5.33%12.13M

-13.63%12.25M

-7.39%15.12M

-11.46%12.23M

-7.50%12.81M

4.68%14.18M

-Accumulated depreciation

-15.99%-2.81M

----

-13.61%-2.42M

----

Other non current assets

----

96.08%271.59K

107.93%279.09K

123.67%292.05K

Total non current assets

-5.29%12.03M

-5.06%11.87M

-7.35%12.13M

-15.37%12.25M

-10.54%12.7M

-10.39%12.5M

-6.39%13.09M

5.82%14.47M

Total assets

-35.45%17.47M

-11.36%18.58M

-19.27%19.9M

-22.45%23.29M

-15.51%27.07M

-16.69%20.96M

-8.87%24.65M

5.88%30.03M

Liabilities

Current liabilities

Payables

-25.28%535K

27.05%1.16M

31.16%1.49M

-10.81%2.16M

-28.33%716K

-41.47%909.88K

-15.21%1.14M

116.99%2.42M

-accounts payable

-25.28%535K

84.64%546K

9.88%651K

1.82%1.31M

-28.33%716K

-71.26%295.72K

-26.80%592.44K

106.52%1.29M

-Other payable

----

-0.68%610K

54.21%843K

-25.21%846K

----

16.81%614.16K

2.34%546.65K

130.30%1.13M

Current accrued expenses

-31.53%849K

----

15.89%1.24M

----

Current debt and capital lease obligation

3.66%396K

-31.96%382K

-93.01%394K

66.58%420K

1.87%382K

-97.23%561.42K

-71.78%5.63M

-98.66%252.13K

-Current debt

----

-98.79%242.13K

-72.70%5.39M

----

-Current capital lease obligation

3.66%396K

19.64%382K

59.63%394K

66.58%420K

1.87%382K

32.32%319.29K

5.19%246.83K

31.34%252.13K

Current liabilities

-23.87%1.78M

4.53%1.54M

-72.13%1.89M

-3.51%2.58M

-4.34%2.34M

-93.26%1.47M

-68.22%6.77M

-86.62%2.67M

Non current liabilities

Long term debt and capital lease obligation

-4.70%20.17M

15.35%19.43M

46.27%24.22M

2.74%22.86M

-26.04%21.16M

818.27%16.84M

791.50%16.56M

1,142.75%22.25M

-Long term debt

-3.56%19.37M

19.70%18.6M

55.66%23.29M

6.63%21.85M

-26.07%20.08M

--15.54M

--14.96M

--20.49M

-Long term capital lease obligation

-26.07%797K

-36.63%823K

-41.86%927K

-42.59%1.01M

-25.45%1.08M

-29.18%1.3M

-14.15%1.59M

-1.93%1.76M

Employee benefits

----

-9.66%26.65K

-6.23%27.36K

4.97%29.87K

Derivative product liabilities

-98.20%96K

--311K

--902K

--2.66M

--5.33M

----

Total non current liabilities

-23.51%20.26M

17.02%19.74M

51.47%25.12M

14.56%25.52M

-7.41%26.49M

726.88%16.87M

642.04%16.59M

932.07%22.28M

Total liabilities

-23.54%22.04M

16.01%21.27M

15.63%27.01M

12.63%28.1M

-7.17%28.83M

-23.15%18.34M

-0.80%23.36M

12.71%24.95M

Shareholders'equity

Share capital

--0

-common stock

--0

Retained earnings

-5.61%-122.34M

-11.59%-120.01M

-10.44%-123.11M

-1.46%-119.35M

-5.27%-115.84M

2.19%-107.54M

-5.21%-111.47M

-17.96%-117.63M

Paid-in capital

2.95%119.51M

8.07%119.05M

4.42%117.74M

-5.12%116.43M

2.66%116.08M

-0.97%110.17M

3.02%112.76M

15.83%122.72M

Gains losses not affecting retained earnings

13.30%-1.74M

---1.74M

---1.89M

2.34%-2.01M

----

Total stockholders'equity

-159.60%-4.57M

-202.52%-2.69M

-652.67%-7.11M

-194.63%-4.81M

-279.23%-1.76M

101.99%2.63M

-63.20%1.29M

-18.41%5.08M

Total equity

-159.60%-4.57M

-202.52%-2.69M

-652.67%-7.11M

-194.63%-4.81M

-279.23%-1.76M

101.99%2.63M

-63.20%1.29M

-18.41%5.08M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-65.40%4.87M	-65.40%4.87M	-22.99%6.36M	-34.02%7.51M	-29.73%10.8M	-18.99%14.08M	-18.99%14.08M	-23.28%8.26M	-7.13%11.38M	5.64%15.37M
-Cash and cash equivalents	-65.40%4.87M	-65.40%4.87M	-22.99%6.36M	-34.02%7.51M	-29.73%10.8M	-18.99%14.08M	-18.99%14.08M	-23.28%8.26M	-7.13%11.38M	5.64%15.37M
Receivables	232.73%366K	232.73%366K	13.97%228K	-23.46%138K	-38.85%119K	12.24%110K	12.24%110K	-54.83%200.04K	-77.77%180.3K	35.09%194.6K
-Other receivables	232.73%366K	232.73%366K	13.97%228K	-23.46%138K	-38.85%119K	12.24%110K	12.24%110K	-54.83%200.04K	-77.77%180.3K	35.09%194.6K
Prepaid assets	57.78%71K	57.78%71K	----	----	----	-80.26%45K	-80.26%45K	----	----	----
Restricted cash	0.00%140K	0.00%140K	--122K	--126K	--127K	-2.10%140K	-2.10%140K	----	----	----
Total current assets	-62.09%5.45M	-62.09%5.45M	-20.67%6.71M	-32.77%7.77M	-29.03%11.05M	-19.46%14.37M	-19.46%14.37M	-24.52%8.46M	-11.52%11.56M	5.93%15.56M
Non current assets
Net PPE	-5.29%12.03M	-5.29%12.03M	-2.95%11.87M	-5.33%12.13M	-13.63%12.25M	-10.54%12.7M	-10.54%12.7M	-11.46%12.23M	-7.50%12.81M	4.68%14.18M
-Gross PPE	-1.89%14.83M	-1.89%14.83M	-2.95%11.87M	-5.33%12.13M	-13.63%12.25M	-7.39%15.12M	-7.39%15.12M	-11.46%12.23M	-7.50%12.81M	4.68%14.18M
-Accumulated depreciation	-15.99%-2.81M	-15.99%-2.81M	----	----	----	-13.61%-2.42M	-13.61%-2.42M	----	----	----
Other non current assets	----	----	----	----	----	----	----	96.08%271.59K	107.93%279.09K	123.67%292.05K
Total non current assets	-5.29%12.03M	-5.29%12.03M	-5.06%11.87M	-7.35%12.13M	-15.37%12.25M	-10.54%12.7M	-10.54%12.7M	-10.39%12.5M	-6.39%13.09M	5.82%14.47M
Total assets	-35.45%17.47M	-35.45%17.47M	-11.36%18.58M	-19.27%19.9M	-22.45%23.29M	-15.51%27.07M	-15.51%27.07M	-16.69%20.96M	-8.87%24.65M	5.88%30.03M
Liabilities
Current liabilities
Payables	-25.28%535K	-25.28%535K	27.05%1.16M	31.16%1.49M	-10.81%2.16M	-28.33%716K	-28.33%716K	-41.47%909.88K	-15.21%1.14M	116.99%2.42M
-accounts payable	-25.28%535K	-25.28%535K	84.64%546K	9.88%651K	1.82%1.31M	-28.33%716K	-28.33%716K	-71.26%295.72K	-26.80%592.44K	106.52%1.29M
-Other payable	----	----	-0.68%610K	54.21%843K	-25.21%846K	----	----	16.81%614.16K	2.34%546.65K	130.30%1.13M
Current accrued expenses	-31.53%849K	-31.53%849K	----	----	----	15.89%1.24M	15.89%1.24M	----	----	----
Current debt and capital lease obligation	3.66%396K	3.66%396K	-31.96%382K	-93.01%394K	66.58%420K	1.87%382K	1.87%382K	-97.23%561.42K	-71.78%5.63M	-98.66%252.13K
-Current debt	----	----	----	----	----	----	----	-98.79%242.13K	-72.70%5.39M	----
-Current capital lease obligation	3.66%396K	3.66%396K	19.64%382K	59.63%394K	66.58%420K	1.87%382K	1.87%382K	32.32%319.29K	5.19%246.83K	31.34%252.13K
Current liabilities	-23.87%1.78M	-23.87%1.78M	4.53%1.54M	-72.13%1.89M	-3.51%2.58M	-4.34%2.34M	-4.34%2.34M	-93.26%1.47M	-68.22%6.77M	-86.62%2.67M
Non current liabilities
Long term debt and capital lease obligation	-4.70%20.17M	-4.70%20.17M	15.35%19.43M	46.27%24.22M	2.74%22.86M	-26.04%21.16M	-26.04%21.16M	818.27%16.84M	791.50%16.56M	1,142.75%22.25M
-Long term debt	-3.56%19.37M	-3.56%19.37M	19.70%18.6M	55.66%23.29M	6.63%21.85M	-26.07%20.08M	-26.07%20.08M	--15.54M	--14.96M	--20.49M
-Long term capital lease obligation	-26.07%797K	-26.07%797K	-36.63%823K	-41.86%927K	-42.59%1.01M	-25.45%1.08M	-25.45%1.08M	-29.18%1.3M	-14.15%1.59M	-1.93%1.76M
Employee benefits	----	----	----	----	----	----	----	-9.66%26.65K	-6.23%27.36K	4.97%29.87K
Derivative product liabilities	-98.20%96K	-98.20%96K	--311K	--902K	--2.66M	--5.33M	--5.33M	----	----	----
Total non current liabilities	-23.51%20.26M	-23.51%20.26M	17.02%19.74M	51.47%25.12M	14.56%25.52M	-7.41%26.49M	-7.41%26.49M	726.88%16.87M	642.04%16.59M	932.07%22.28M
Total liabilities	-23.54%22.04M	-23.54%22.04M	16.01%21.27M	15.63%27.01M	12.63%28.1M	-7.17%28.83M	-7.17%28.83M	-23.15%18.34M	-0.80%23.36M	12.71%24.95M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-5.61%-122.34M	-5.61%-122.34M	-11.59%-120.01M	-10.44%-123.11M	-1.46%-119.35M	-5.27%-115.84M	-5.27%-115.84M	2.19%-107.54M	-5.21%-111.47M	-17.96%-117.63M
Paid-in capital	2.95%119.51M	2.95%119.51M	8.07%119.05M	4.42%117.74M	-5.12%116.43M	2.66%116.08M	2.66%116.08M	-0.97%110.17M	3.02%112.76M	15.83%122.72M
Gains losses not affecting retained earnings	13.30%-1.74M	13.30%-1.74M	---1.74M	---1.74M	---1.89M	2.34%-2.01M	2.34%-2.01M	----	----	----
Total stockholders'equity	-159.60%-4.57M	-159.60%-4.57M	-202.52%-2.69M	-652.67%-7.11M	-194.63%-4.81M	-279.23%-1.76M	-279.23%-1.76M	101.99%2.63M	-63.20%1.29M	-18.41%5.08M
Total equity	-159.60%-4.57M	-159.60%-4.57M	-202.52%-2.69M	-652.67%-7.11M	-194.63%-4.81M	-279.23%-1.76M	-279.23%-1.76M	101.99%2.63M	-63.20%1.29M	-18.41%5.08M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall